New-onset mental illness among gestational carriers
Velez MP, Dayan N, Vigod SN, Buckett W, Flatt S, Shellenberger J, Ray JG. JAMA Netw Open. 2025 Jul 25.
Publications
Suicide following discharge from inpatient psychiatric care: a retrospective case control study
Thompson C, Sieffien W, Iwajomo T, Mason J, de Oliveira C, Rudoler D, Husain I, Kurdyak P, Zaheer J. Psychiatry Res. 2025; 351:116645. Epub 2025 Jul 18.
Contact with health services for adverse childhood experiences and subsequent risk of non-affective psychotic disorder: population-based evidence from Ontario, Canada
Salama R, Rodrigues R, Comeau J, Choi YH, Rotenberg M, Edwards J, Le B, Anderson KK. Schizophr Res. 2025; 283:115-121. Epub 2025 Jul 16.
Assessing the impact of the introduction of generic methadone to the Ontario public drug formulary
Hamzat B, Wang T, Garg R, Iacono A, Tadrous M, Wu F, Wyman J, Dodd Z, Pinkerton S, Smoke A, Gomes T. Int J Drug Policy. 2025; 143:104918. Epub 2025 Jul 10.
Early psychosis symptoms noted by family physicians in electronic medical records during help-seeking visits in primary care
Wiener JC, Rodrigues R, Reid JNS, Archie S, Jan SH, MacDougall AG, Palaniyappan L, Jaakkimainen L, Chen B, Sawh N, Anderson KK; project co-investigators. Can J Psychiatry. 2025 Jul 7 [Epub ahead of print].
Group B Streptococcus disease during infancy and risk of subsequent neurodevelopmental impairments in young children: a population-based cohort study in Ontario, Canada
Fakhraei R, Fell DB, El-Chaar D, Thampi N, Sander B, Brown KA, Crowcroft N, Bolotin S, Barrett J, Darling EK, Fittipaldi N, Lamagni T, McGeer A, Murti M, Sadarangani M, Schwartz KL, Yasseen A, Tunis M, Petrcich W, Wilson K. Lancet Reg Health Am. 2025; 48: 101170.
Duration of methadone and buprenorphine-naloxone treatment
Kleinman RA, Kurdyak P. JAMA Netw Open. 2025; 8(7):e2518389.
Retention in opioid agonist therapy among First Nations people in Ontario, Canada: a retrospective cohort study
Holton A, Hamzat B, McCormack D, Bragg S, deGonzague B, Mecredy G, Campbell T, Antoniou T, McGregor L, Bertram J, Gomes T. JAMA Netw Open. 2025; 8(6):e2518452.
Changing trends in safer opioid supply uptake, dose and hydromorphone volume in Ontario: a population-based cross-sectional study
Xu F, Wang T, Kolla G, Campbell T, Watts T, Ledlie S, Koncz D, Tadrous M, Gomes T. Int J Drug Policy. 2025; 143:104905. Epub 2025 Jun 28.
Health care use, care settings, and location of death for people with schizophrenia in long-term care
Dover K, Fiedorowicz JG, Kirkwood D, Solmi M, Bolton JM, Isenberg SR, Li W, Mahar A, Bush SH, Bonares M, Edwards JD, Hatcher S, Dosani N, Lawlor P, Chochinov HM, Kurdyak P, Wellman M, Franck C, Rochon A, Tanuseputro P, Webber C. J Am Med Dir Assoc. 2025; Jun 13 [Epub ahead of print].